Ultra-small radiosensitizers deliver epigenetic drugs to induce pyroptosis and boost triple-negative breast cancer radiotherapy

Ruixue Liu,Ronghua Wang,Maoru Zhao,Yaping Liu,Xianyu Zhu,Xiaochen Wu,Shuanglong Du,Zhanjun Gu,Jiangfeng Du
DOI: https://doi.org/10.1016/j.nantod.2023.101997
IF: 17.4
2023-09-23
Nano Today
Abstract:The pyroptosis of tumor cells can elicit a potent anti-tumor immune response, offering a promising approach to the therapy of triple-negative breast cancer (TNBC) and the prevention of tumor recurrence and metastasis. This study developed a nanocomposite system of ultra-small hafnium oxide nanoparticles (HfO 2 NPs) loaded with Decitabine (DAC) to effectively transform radiation-induced tumor cell apoptosis into pyroptosis. Initially, DAC was delivered efficiently to the tumor tissues, owing to the well tumor osmosis and retention of HfO 2 NPs. Furthermore, HfO 2 NPs can generate more reactive oxygen species to activate Caspase-3 upon ionizing radiation. Ultimately, DAC can effectively suppress DNA methyltransferase, reverse the silencing state of GSDME in TNBC cells, and convert apoptosis into pyroptosis. Pyroptosis can activate more powerful anti-tumor immunity and effectively inhibit tumor metastasis. This study not only addresses the concerns of significant side effects and low induction rate of conventional pyroptosis-inducing drugs but also provides a novel strategy for the treatment of malignancies with low GSDME expression and extends the application of pyroptosis.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?